Perceptive Advisors LLC
- SEC CIK
- 0001224962
- 最新申報
- 2026/8/14
2021 年第 4 季持倉
持倉截至 2021/12/31，2022/5/4 申報。只含多頭部位，變化是跟 2021 年第 3 季比股數。
- 持股檔數
- 145
- 較 2021 年第 3 季 +7
- 總值
- $64.7 億
- 較 2021 年第 3 季 −$3.89 億 (−5.7%)
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| ISOIsoPlexis Corp | COM | 4,095,498 | $3,764 萬 | 0.6% | +4,095,498 | 新進 | 歷史 |
| OMICSingular Genomics Systems, Inc. | COM | 3,333,824 | $3,854 萬 | 0.6% | +260,000+8.5% | 加碼 | 歷史 |
| ALDXAldeyra Therapeutics, Inc. | COM | 9,903,879 | $3,962 萬 | 0.6% | 00.0% | 不變 | 歷史 |
| MORFMorphic Holding, Inc. | COM | 836,521 | $3,963 萬 | 0.6% | −50,819−5.7% | 減碼 | 歷史 |
| NBIXNeurocrine Biosciences Inc | Stock | 483,007 | $4,114 萬 | 0.6% | 00.0% | 不變 | 歷史 |
| QTNTQuotient Ltd | SHS | 16,200,818 | $4,196 萬 | 0.6% | 00.0% | 不變 | 歷史 |
| RCKTRocket Pharmaceuticals, Inc. | COM | 1,959,125 | $4,277 萬 | 0.7% | −351,136−15.2% | 減碼 | 歷史 |
| ICVXIcosavax, Inc. | COM | 1,906,548 | $4,362 萬 | 0.7% | −16,001−0.8% | 減碼 | 歷史 |
| KODKodiak Sciences Inc. | COM | 520,152 | $4,410 萬 | 0.7% | +58,904+12.8% | 加碼 | 歷史 |
| LONALeonaBio, Inc. | COM | 3,425,916 | $4,464 萬 | 0.7% | 00.0% | 不變 | 歷史 |
| ARNAArena Pharmaceuticals Inc | COM NEW | 500,000 | $4,647 萬 | 0.7% | +500,000 | 新進 | 歷史 |
| NAUTNautilus Biotechnology, Inc. | COM | 9,111,151 | $4,720 萬 | 0.7% | +200,000+2.2% | 加碼 | 歷史 |
| Coherus Biosciences Inc19249HAB9 | NOTE 1.500% 4/1 | – | $5,149 萬 | 0.8% | – | – | – |
| ChemoCentryx, Inc.16383L106 | COM | 1,415,446 | $5,154 萬 | 0.8% | +865,446+157.4% | 加碼 | – |
| ALBOAlbireo Pharma, Inc. | COM | 2,360,139 | $5,497 萬 | 0.8% | 00.0% | 不變 | 歷史 |
| TVTXTravere Therapeutics, Inc. | COM | 1,845,555 | $5,729 萬 | 0.9% | −120,000−6.1% | 減碼 | 歷史 |
| INBXInhibrx Biosciences, Inc. | COM | 1,343,490 | $5,867 萬 | 0.9% | +222,000+19.8% | 加碼 | 歷史 |
| RLAYRelay Therapeutics, Inc. | COM | 1,943,097 | $5,967 萬 | 0.9% | 00.0% | 不變 | 歷史 |
| ZYMEZymeworks Inc. | COM | 3,679,845 | $6,031 萬 | 0.9% | 00.0% | 不變 | 歷史 |
| Bellus Health Inc New07987C204 | COM NEW | 7,645,234 | $6,154 萬 | 1.0% | +7,645,234 | 新進 | – |
| APLSApellis Pharmaceuticals, Inc. | COM | 1,451,700 | $6,864 萬 | 1.1% | +836,700+136.0% | 加碼 | 歷史 |
| CCCCC4 Therapeutics, Inc. | COM STK | 2,208,913 | $7,113 萬 | 1.1% | −49,653−2.2% | 減碼 | 歷史 |
| LABPLandos Biopharma, Inc. | COM | 14,869,915 | $7,138 萬 | 1.1% | 00.0% | 不變 | 歷史 |
| XENEXenon Pharmaceuticals Inc. | COM | 2,411,447 | $7,533 萬 | 1.2% | +389,396+19.3% | 加碼 | 歷史 |
| OMOutset Medical, Inc. | COM | 1,863,397 | $8,588 萬 | 1.3% | −127,236−6.4% | 減碼 | 歷史 |
| CHRSCoherus Oncology, Inc. | COM | 5,407,798 | $8,631 萬 | 1.3% | +628,411+13.1% | 加碼 | 歷史 |
| GBTGlobal Blood Therapeutics, Inc. | COM | 3,449,915 | $1.01 億 | 1.6% | −957,484−21.7% | 減碼 | 歷史 |
| Nevro Corp64157FAC7 | NOTE 2.750% 4/0 | – | $1.02 億 | 1.6% | – | – | – |
| BMRNBiomarin Pharmaceutical Inc | COM | 1,180,000 | $1.04 億 | 1.6% | +1,180,000 | 新進 | 歷史 |
| RAPTRAPT Therapeutics, Inc. | COM | 2,927,565 | $1.08 億 | 1.7% | +20,000+0.7% | 加碼 | 歷史 |
| ISEEIVERIC bio, Inc. | COM | 6,480,000 | $1.08 億 | 1.7% | −991,798−13.3% | 減碼 | 歷史 |
| BBIOBridgeBio Pharma, Inc. | COM | 7,128,755 | $1.19 億 | 1.8% | −628,173−8.1% | 減碼 | 歷史 |
| VBIVVBI Vaccines Inc/BC | COM NEW | 52,335,002 | $1.22 億 | 1.9% | −2,707,463−4.9% | 減碼 | 歷史 |
| RXDXPrometheus Biosciences, Inc. | COM | 3,172,785 | $1.25 億 | 1.9% | −141,247−4.3% | 減碼 | 歷史 |
| CRNXCrinetics Pharmaceuticals, Inc. | COM | 5,163,517 | $1.47 億 | 2.3% | +1,200,000+30.3% | 加碼 | 歷史 |
| CERECerevel Therapeutics Holdings, Inc. | COM | 5,086,727 | $1.65 億 | 2.5% | 00.0% | 不變 | 歷史 |
| MGTXMeiraGTx Holdings plc | COM | 6,948,277 | $1.65 億 | 2.5% | 00.0% | 不變 | 歷史 |
| Collegium Pharmaceutical, Inc19459JAA2 | NOTE 2.625% 2/1 | – | $1.69 億 | 2.6% | – | – | – |
| HZNPHorizon Therapeutics Public Ltd Co | SHS | 1,738,140 | $1.87 億 | 2.9% | −218,800−11.2% | 減碼 | 歷史 |
| IOVAIovance Biotherapeutics, Inc. | COM | 10,127,941 | $1.93 億 | 3.0% | −1,361,831−11.9% | 減碼 | 歷史 |
| SWTXSpringWorks Therapeutics, Inc. | COM | 4,849,912 | $3.01 億 | 4.6% | 00.0% | 不變 | 歷史 |
| FOLDAmicus Therapeutics, Inc. | COM | 26,559,443 | $3.07 億 | 4.7% | 00.0% | 不變 | 歷史 |
| LIANYLianBio | SPONSORED ADS | 56,319,960 | $3.47 億 | 5.4% | +56,319,960 | 新進 | 歷史 |
| MRTXMirati Therapeutics, Inc. | COM | 3,283,783 | $4.82 億 | 7.4% | −103,962−3.1% | 減碼 | 歷史 |
| Retrophin Inc761299AB2 | NOTE 2.500% 9/1 | – | $4.85 億 | 7.5% | – | – | – |
選擇權（2 檔）
同一份申報裡的賣權（put）與買權（call）。金額是標的股票的市值，也就是 13F 申報的數字。
2021 年第 3 季之後清倉（15 檔）
2021 年第 3 季季末還持有、這份申報已經沒有的部位。
| 證券 | 類別 | 2021 年第 3 季股數 | 2021 年第 3 季市值 | 2021 年第 3 季佔組合 % | 紀錄 |
|---|---|---|---|---|---|
| AVIRAtea Pharmaceuticals, Inc. | COM | 2,259,224 | $7,921 萬 | 1.2% | 歷史 |
| BEAMBeam Therapeutics Inc. | COM | 537,635 | $4,678 萬 | 0.7% | 歷史 |
| DBVTDBV Technologies S.A. | SPONSORED ADR | 7,695,505 | $3,771 萬 | 0.5% | 歷史 |
| Avidity Biosciences, Inc.05370A108 | COM | 885,818 | $2,182 萬 | 0.3% | – |
| NTRANatera, Inc. | COM | 160,000 | $1,783 萬 | 0.3% | 歷史 |
| CM Life Sciences III Inc125841205 | UNIT 04/30/2028 | 1,250,000 | $1,281 萬 | 0.2% | – |
| PODDInsulet Corp | Stock | 44,522 | $1,265 萬 | 0.2% | 歷史 |
| FDMT4D Molecular Therapeutics, Inc. | COM | 375,256 | $1,012 萬 | 0.1% | 歷史 |
| TSHATaysha Gene Therapies, Inc. | COM SHS | 320,440 | $596.7 萬 | 0.1% | 歷史 |
| PSTXPoseida Therapeutics, Inc. | COM | 787,745 | $574.3 萬 | 0.1% | 歷史 |
| ATECAlphatec Holdings, Inc. | COM NEW | 430,900 | $525.2 萬 | 0.1% | 歷史 |
| RGNXREGENXBIO Inc. | COM | 89,283 | $374.3 萬 | 0.1% | 歷史 |
| SNCEScience 37 Holdings, Inc. | COM | 300,000 | $294.0 萬 | <0.1% | 歷史 |
| IMGOImago BioSciences, Inc. | COM | 125,000 | $250.4 萬 | <0.1% | 歷史 |
| KRROKorro Bio, Inc. | COM | 222,222 | $156.9 萬 | <0.1% | 歷史 |